The National Institute for Health and Care Excellence (NICE) guideline NG28 recognises both drug classes as treatment options within the type 2 diabetes management pathway
Samples were separated using a Raptor HILIC-Si 2.1 100 mm, 2.7 m LC column (Restek) with a constant flow rate of 400 l/min following a flow gradient starting at 5% Mobile Phase B (H 2 O + 5 mM AmFm +0.5% formic acid) then going up to 40% in 5 min, which was followed by re-equilibration at 5% B for 4 min and 30s
Over time, the peptide structure can break down, making it less effective
For individuals with obesity or clear insulin resistance, this degree of weight reduction can meaningfully improve blood sugar control, blood pressure, inflammatory markers, and overall cardiometabolic risk
GHK-Cu inhibits this signal, helping hair stay in the growth phase longer
Tirzepatide is a different molecule (a dual GIP/GLP-1 agonist) that produces greater average weight loss in head-to-head trials